03:39 AM EST, 12/04/2025 (MT Newswires) -- William Guyer, Chief Development Officer, on December 01, 2025, sold 20,000 shares in Corcept Therapeutics ( CORT ) for $1,601,526. Following the Form 4 filing with the SEC, Guyer has control over a total of 1,235 common shares of the company, with 1,235 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/xslF345X05/ownership.xml